St. Jude Children's Research Hospital ® channels support of Radio One, Inc., Yolanda Adams, Hezekiah Walker and James Fortune
MEMPHIS, Tenn., April 11, 2013 /PRNewswire-USNewswire/ -- With efforts led by Radio One, Inc., the largest radio company primarily targeting African-American and urban listeners, nationally syndicated inspiration shows across the country helped raise $1,126,000 so St. Jude Children's Research Hospital® can continue its research discoveries to save the lives of countless children around the world. Supporters like Yolanda Adams, Coco Brother, Hezekiah Walker, James Fortune and nearly 60 partner stations hit the airwaves on April 4 to help kids fighting cancer, sickle cell and other deadly diseases.
Radio Cares for St. Jude Kids ® is a radio fundraising event that shares touching stories of St. Jude patients and families, and since 2008, has raised more than $15 million in cash and pledges. GRAMMY Award-winning gospel singer Yolanda Adams helped kick off the celebration at 6 a.m. EST on the Yolanda Adams Morning Show, while Cory Condrey wrapped up the radiothon at 11 p.m. EST with special coverage on the CoCo Brother Live show."Our listeners are always so supportive of St. Jude Children's Research Hospital and its lifesaving mission," said Yolanda Adams. "Every child should have the opportunity to enjoy life's special moments – big and small – and cancer should not be a child's only defining moment. With the help of my radio colleagues and fans, we are so proud to raise millions of dollars to help save lives." Adams is referring to children like Kayla who joined other patients to share their St. Jude experiences with listeners across the country. Diagnosed with acute lymphoblastic leukemia (ALL), the most common form of childhood cancer, Kayla is currently being treated at St. Jude. But she hasn't let that stop her from enjoying life's special moments. Kayla is a diva who loves fashion, keeping up with the latest trends and singing. This is all possible today, thanks to research and treatment protocols developed at St. Jude, which have pushed survival rates for ALL from 4 to 94 percent.